True generic of Flovent HFA inhaler now approved
After a Senate investigation into GSK's discontinuation of the Flovent HFA inhaler in 2024 and the subsequent increase in hospitalizations of children with asthma, a generic version of the inhaler is now available. Flovent HFA remains off the market.
Authors
- Diane S. Aschenbrenner
Institutions
- Johns Hopkins University (US)
- The Dialogue (US)
Publication Details
- Journal
- AJN American Journal of Nursing
- Published
- 2026-06-25
- DOI
- https://doi.org/10.1097/ajn.0000000000000331a
- Primary Topic
- Inhalation and Respiratory Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00